APREMILAST Accord cpr pellic 10 mg 4+4+19 pce

7680703000014 CH-70300 L04AA32 07.15.0.

Active substances:

No images available

Details

Product number
7030001
CPT
-
Packaging group
4 + 4 + 19
Unit
Tablette(n)
Composition
I) 10 mg: apremilastum 10 mg, lactosum monohydricum 66.67 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium max. 0.33 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, E 171, monoglyceriderorum diacetylates, E 172 (rubrum), pro compresso obducto. II) 20 mg: apremilastum 20 mg, lactosum monohydricum 133.34 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium max. 0.66 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, E 171, monoglyceriderorum diacetylates, E 172 (flavum), E 172 (rubrum), pro compresso obducto. III) 30 mg: apremilastum 30 mg, lactosum monohydricum 200.01 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.99 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, E 171, monoglyceriderorum diacetylates, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto.

Articles (1)

Apremilast Accord 10 mg, 20 mg, 30 mg, Filmtabletten
Filmtabletten
4 + 4 + 19
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
04/08/2026
Professional SmPC
Français
04/08/2026
Professional SmPC
Italien
04/08/2026
Patient information leaflet
Allemand
12/05/2026
Patient information leaflet
Français
12/05/2026
Patient information leaflet
Italien
12/05/2026

Detailed composition

Substance Quantity Type Category
apremilastum
30.0 MG Substance Wirkstoff (Principe actif)
apremilastum
20.0 MG Substance Wirkstoff (Principe actif)
apremilastum
10.0 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
133.34 MG Substance HBESI
lactosum monohydricum
200.01 MG Substance HBESI
lactosum monohydricum
66.67 MG Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
natrium
- Substance HBESI
natrium
0.99 MG Substance HBESI
natrium
- Substance HBESI
silica colloidalis anhydrica
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
magnesii stearas
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 171
- Substance FNIDK
E 171
- Substance FNIDK
E 171
- Substance FNIDK
monoglyceriderorum diacetylates
- Substance HNIDK
monoglyceriderorum diacetylates
- Substance HNIDK
monoglyceriderorum diacetylates
- Substance HNIDK
E 172 (flavum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 172 (nigrum)
- Substance FTODK

Reimbursement information

Public price
CHF 131.05
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/09/2026

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
70300
Drug name
Apremilast Accord, Filmtabletten
Galenic form
FILM
ATC Code
L04AA32
Authorization status
Z
Dispensation category
B
First authorization
21/01/2026
Authorization expiration date
20/01/2031
IT number
07.15.0.
Domain
Human medicine
Field of application
Aktive Psoriasis-Arthritis und mittelschwere bis schwere Plaque-Psoriasis

Packaging details

Description (FR)
APREMILAST Accord cpr pellic 10 mg 4+4+19 pce
Description (DE)
APREMILAST Accord Filmtabl 10 mg 4+4+19 Stk
Market launch
01/09/2026
Narcotic (BTM)
No

Original drug

Otezla, Filmtabletten
CHF 334.85
View original

Other packaging sizes

APREMILAST Accord cpr pellic 30 mg 56 pce
56 TABL
View
Buy us a coffee Explore the data